Global Killed-type Poultry Vaccine Market Growth 2025-2031

The global Killed-type Poultry Vaccine market size is predicted to grow from US$ 3366 million in 2025 to US$ 4373 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 589%.

LP Information, Inc. (LPI) ' newest research report, the “Killed-type Poultry Vaccine Industry Forecast” looks at past sales and reviews total world Killed-type Poultry Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Killed-type Poultry Vaccine sales for 2025 through 2031. With Killed-type Poultry Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Killed-type Poultry Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Killed-type Poultry Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Killed-type Poultry Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Killed-type Poultry Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Killed-type Poultry Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Killed-type Poultry Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Killed-type Poultry Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other

Segmentation by Application:
Chicken
Other Poultry

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY’S

Key Questions Addressed in this Report

What is the 10-year outlook for the global Killed-type Poultry Vaccine market?

What factors are driving Killed-type Poultry Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Killed-type Poultry Vaccine market opportunities vary by end market size?

How does Killed-type Poultry Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.